The launch expands access in the region to dual-energy catheter ablation for personalized care across workflows, anatomies and procedural strategies.
J&J’s ThermoCool SmartTouch platform combines the ThermoCool SmartTouch SF catheter with the TruPulse generator. Combining the irrigated contact-force-sensing catheter with TruPulse enables the delivery of both radiofrequency (RF) and pulsed field (PF) energy. It all takes place through a single catheter-based solution. Dual-ablation continues to heat up, with Abbott also advancing its TactiFlex Duo platform.
ThermoCool SmartTouch combines a point-by-point workflow with the flexibility to tailor treatment approaches across a range of procedures. It leverages Carto integration, ultra-high-density mapping solutions and intracardiac ultrasound imaging. This enables the delivery of advanced electro-anatomical mapping, catheter visualization, contact-force feedback and PF/RF Index guidance.
One-year outcomes shared last year showed that the dual-energy catheter proved 86.9% effective when treating patients with high adherence to recommended ablation parameters.
Ricardo Martin, president, EMEA, Electrophysiology, MedTech, Johnson & Johnson, said:
“No two atrial fibrillation patients are the same, which is why personalized treatment and procedural versatility matter. The launch of the Dual Energy THERMOCOOL SMARTTOUCH SF Platform reflects our continued commitment to providing physicians with a broad range of treatment options. As the latest addition to our integrated pulsed field ablation portfolio, it combines the familiarity of the world’s leading radiofrequency catheter with the versatility of pulsed field ablation, giving physicians greater confidence to tailor treatment to each patient’s needs.”
